Free Trial

Bone Biologics (BBLGW) Institutional Ownership

Bone Biologics logo
$20.80 0.00 (0.00%)
As of 02/21/2025

Institutional Ownership Changes (13F Filings) for Bone Biologics (NASDAQ:BBLGW)

Number of
Institutional Buyers
(last 12 months)
0
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$79.84K
Get BBLGW Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Bone Biologics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Citadel Advisors LLC34,755$1.48M0.0%-5.4%0.000%
5/13/2022 Warberg Asset Management LLC109,567$38K0.0%+180.9%0.000%
(Data available from 1/1/2016 forward)

BBLGW Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BBLGW shares?

During the previous two years, the following institutional investors and hedge funds held shares of Bone Biologics shares: Citadel Advisors LLC ($1.48M).Learn more on BBLGW's institutional investors.

Which Bone Biologics major shareholders have been selling company stock?

The following institutional investors have sold Bone Biologics stock in the last 24 months: Citadel Advisors LLC ($2.00K).

How much institutional selling is happening at Bone Biologics?

Institutional investors have sold a total of 1,996 shares in the last 24 months. This volume of shares sold represents approximately $79.84K in transactions.



This page (NASDAQ:BBLGW) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners